S La Vignera1, R A Condorelli2, R Cannarella2, F Giacone2, L Mongioi'2, G Scalia3, V Favilla4, G I Russo4, S Cimino4, G Morgia4, A E Calogero2. 1. Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. sandrolavignera@unict.it. 2. Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. 3. Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy. 4. Urology Section, Department of Surgery, University of Catania, Catania, Italy.
Abstract
BACKGROUND: Papillomavirus (HPV) often occurs in the semen of patients with male accessory gland infection (MAGI). Ultrasound (US) evaluation has been suggested as a promising diagnostic tool for patients with HPV-related MAGI. No data on the spontaneous clearance of HPV-DNA have been reported so far in HPV-related MAGI. PURPOSE: The primary aim of the study was to assess the percentage of early HPV-DNA spontaneous clearance in patients with prostatitis. The secondary aim was to evaluate the frequency of spontaneous clearance of HPV-DNA among patients with prostatitis associated with the presence or absence of US abnormalities. METHODS: Patients with inflammatory MAGI and at least one suspicious criterion for HPV infection underwent semen HPV-DNA detection and prostate US. The presence of HPV-DNA was further investigated after a 6-month-long follow-up. MAIN RESULTS: Eighty patients satisfied the inclusion criteria and were recruited in the study. 69% of patients (55/80) showed HPV-DNA persistence in the semen. Among them, 82% (45/55) was positive for US signs of prostatitis, while they occurred only in 12% (3/25) of those patients with no sign of HPV-DNA persistence (p < 0.001). All patients with persistent high-risk HPV genotype (n = 30) showed at least two US signs of prostatitis. In 73% of patients (22/30), E6 and E7 mRNAs were detected. CONCLUSION: US signs of prostatitis more frequently occurred in patients with evidence of HPV-DNA persistence on semen, especially in those with high-risk genotypes. This highlights the importance of US in the framework of HPV-related MAGI.
BACKGROUND:Papillomavirus (HPV) often occurs in the semen of patients with male accessory gland infection (MAGI). Ultrasound (US) evaluation has been suggested as a promising diagnostic tool for patients with HPV-related MAGI. No data on the spontaneous clearance of HPV-DNA have been reported so far in HPV-related MAGI. PURPOSE: The primary aim of the study was to assess the percentage of early HPV-DNA spontaneous clearance in patients with prostatitis. The secondary aim was to evaluate the frequency of spontaneous clearance of HPV-DNA among patients with prostatitis associated with the presence or absence of US abnormalities. METHODS:Patients with inflammatory MAGI and at least one suspicious criterion for HPV infection underwent semen HPV-DNA detection and prostate US. The presence of HPV-DNA was further investigated after a 6-month-long follow-up. MAIN RESULTS: Eighty patients satisfied the inclusion criteria and were recruited in the study. 69% of patients (55/80) showed HPV-DNA persistence in the semen. Among them, 82% (45/55) was positive for US signs of prostatitis, while they occurred only in 12% (3/25) of those patients with no sign of HPV-DNA persistence (p < 0.001). All patients with persistent high-risk HPV genotype (n = 30) showed at least two US signs of prostatitis. In 73% of patients (22/30), E6 and E7 mRNAs were detected. CONCLUSION: US signs of prostatitis more frequently occurred in patients with evidence of HPV-DNA persistence on semen, especially in those with high-risk genotypes. This highlights the importance of US in the framework of HPV-related MAGI.
Authors: Sandro La Vignera; Rosita A Condorelli; Enzo Vicari; Mario Salmeri; Giuseppe Morgia; Vincenzo Favilla; Sebastiano Cimino; Aldo E Calogero Journal: J Med Microbiol Date: 2013-09-26 Impact factor: 2.472
Authors: Giorgio I Russo; Aldo E Calogero; Rosita A Condorelli; Guido Scalia; Giuseppe Morgia; Sandro La Vignera Journal: Aging Male Date: 2018-03-23 Impact factor: 5.892
Authors: S La Vignera; A E Calogero; R A Condorelli; L O Vicari; M Catanuso; R D'Agata; E Vicari Journal: Andrologia Date: 2011-09-15 Impact factor: 2.775
Authors: Andrea Garolla; Bruno Engl; Damiano Pizzol; Marco Ghezzi; Alessandro Bertoldo; Alberto Bottacin; Marco Noventa; Carlo Foresta Journal: Fertil Steril Date: 2015-10-09 Impact factor: 7.329
Authors: A Ferlin; A E Calogero; C Krausz; F Lombardo; D Paoli; R Rago; C Scarica; M Simoni; C Foresta; V Rochira; E Sbardella; S Francavilla; G Corona Journal: J Endocrinol Invest Date: 2022-01-24 Impact factor: 4.256
Authors: Francesco Muscianisi; Luca De Toni; Gloria Giorato; Andrea Carosso; Carlo Foresta; Andrea Garolla Journal: Front Endocrinol (Lausanne) Date: 2021-03-08 Impact factor: 5.555
Authors: Luca De Toni; Francesco Muscianisi; Christian Corsini; Marco Ghezzi; Andrea Di Nisio; Carlo Foresta; Andrea Garolla Journal: Vaccines (Basel) Date: 2020-12-07
Authors: Sandro La Vignera; Livia Basile; Antonio Aversa; Aldo E Calogero; Agata Grillo; Rossella Cannarella; Laura M Mongioì; Rosita A Condorelli Journal: J Clin Med Date: 2022-08-11 Impact factor: 4.964
Authors: Sandro La Vignera; Andrea Crafa; Rosita A Condorelli; Federica Barbagallo; Laura M Mongioì; Rossella Cannarella; Michele Compagnone; Antonio Aversa; Aldo E Calogero Journal: Andrology Date: 2021-05-04 Impact factor: 3.842